Skip to main content
SpringerLink
Log in

Colonisation and Infection with Resistant Gram-Positive Cocci

Epidemiology and Risk Factors

  • Published:
Drugs Aims and scope Submit manuscript

Summary

Only a few years after the introduction of penicillin, resistant staphylococci were isolated in hospitals. This situation has led to the development of semisyn-thetic penicillins. Today, multiresistant Gram-positive bacteria have become an increasing problem in both hospitals and the community, frequently leaving the glycopeptides as the only therapeutic option. Notable problem pathogens are methicillin-resistant Staphylococcus aureus, coagulase-negative staphylococci and glycopeptide-resistant enterococci in the nosocomial environment, and penicillin-resistant Streptococcuspneumoniae in the community. In the hospital setting, as well as in the community and in animal husbandry, crowding and poor hygiene can facilitate the spread of resistant bacteria selected by antibiotic usage. However, the precise epidemiology and frequency of each drug-resistant pathogen depends on geographical location, the patient group involved and previous antibiotic use. Active measures need to be taken to reduce the spread of these pathogens and thus preserve the efficacy of available antibiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial aetiology of nosocomial infection. Am J Med 1991; 91 Suppl. 3B: 72–5S

    Article  Google Scholar 

  2. Cormican MG, Jones RN. Emerging resistance to antimicrobial agents in Gram-positive bacteria — enterococci, staphylococci and nonpneumococcal streptococci. Drugs 1996; 51 Suppl. 1: 6–12

    Article  PubMed  CAS  Google Scholar 

  3. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995; 274: 639–44

    Article  PubMed  CAS  Google Scholar 

  4. Bates J, Jordens Z, Selkon JB. Evidence for an animal origin of vancomycin resistant enterococci. Lancet 1993; 342: 490–1

    Article  PubMed  CAS  Google Scholar 

  5. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72: 195–8

    Article  PubMed  CAS  Google Scholar 

  6. Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991; 28 Suppl. C: 31–8

    Article  PubMed  CAS  Google Scholar 

  7. Seppala H, Klaukka T, Lehtonen R, et al. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995; 21: 1378–85

    Article  PubMed  CAS  Google Scholar 

  8. Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135–6

    Article  PubMed  CAS  Google Scholar 

  9. Arason VA, Kristinsson KG, Sigurdsson JA, et al. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996; 313: 387–91

    Article  PubMed  CAS  Google Scholar 

  10. Baquero F. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J Antimicrob Chemother 1996; 38 Suppl. A: 117–32

    Article  PubMed  CAS  Google Scholar 

  11. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995; 171: 614–24

    Article  PubMed  CAS  Google Scholar 

  12. Uhari M, Mottonen M. Infection prevention in child day care centers [abstract K180]. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1995 Sep 17–20: San Francisco. Washington DC: American Society for Microbiology, 1995

    Google Scholar 

  13. Neu HC. The crisis in antibiotic resistance. Science 1992; 257: 1064–73

    Article  PubMed  CAS  Google Scholar 

  14. Mouthon L, Mainardi J-L. Vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus: the gram-positive challenges. Curr Opin Infect Dis 1996; 9: 256–60

    Article  Google Scholar 

  15. Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50–5

    Article  PubMed  CAS  Google Scholar 

  16. Doebbeling BN. The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection. J Chemother 1995; 7 Suppl. 3: 99–103

    PubMed  Google Scholar 

  17. Cox RA, Mallaghan C, Conquest C, et al. Epidemic methicillin-resistant Staphylococcus aureus: controlling the spread outside hospital. J Hosp Infect 1995; 29: 107–9

    Article  PubMed  CAS  Google Scholar 

  18. Goldstein FW, Pean Y, Gertner J, et al. Resistance to ceftriaxone and other beta-lactams in bacteria isolated in the community. Antimicrob Agents Chemother 1995; 39: 2516–9

    Article  PubMed  CAS  Google Scholar 

  19. Peters G, von Eiff C, Herrmann M. The changing pattern of coagulase-negative staphylococci as infectious pathogens. Curr Opin Infect Dis 1995; 8 Suppl. 1: S12–9

    Article  Google Scholar 

  20. Hedin G, Hambraeus A. Multiply antibiotic-resistant Staphylococcus epidermidis in patients, staff and environment — a one week survey in a bone marrow transplant unit. J Hosp Infect 1991; 17: 95–106

    Article  PubMed  CAS  Google Scholar 

  21. Daschner FD, Kropec A. Glycopeptides in the treatment of staphylococcal infections. Eur J Clin Microbiol Infect Dis 1995; 14 Suppl. 1: S12–7

    PubMed  Google Scholar 

  22. Leclercq R. Epidemiology and control of multiresistant enterococci. Drugs 1996; 52 Suppl. 2: 47–9

    Article  PubMed  Google Scholar 

  23. Leclercq R, Courvalin P. Emerging problems with enterococcal infections. Curr Opin Infect Dis 1996; 9: 115–9

    Article  Google Scholar 

  24. Clark NC, Cooksey RC, Hill BC, et al. Characterisation of gly-copeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993; 37: 2311–7

    Article  PubMed  CAS  Google Scholar 

  25. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents including vancomycin. Ann Intern Med 1995; 123: 250–9

    PubMed  CAS  Google Scholar 

  26. Gin AS, Zhanel GG. Vancomycin-resistant enterococci. Ann Pharmacother 1996; 30: 615–24

    PubMed  CAS  Google Scholar 

  27. Tornieporth NG, Roberts RB, John J, et al. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonisation in 145 matched case patients and control patients. Clin Infect Dis 1996; 23: 767

    Article  PubMed  CAS  Google Scholar 

  28. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126–33

    Article  PubMed  CAS  Google Scholar 

  29. Van der Auwera P, Pensart N, Korten V, et al. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129–36

    Article  PubMed  Google Scholar 

  30. Klare I, Heier H, Claus H, et al. Enterococcus faecium strains with vanA mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist 1995; 1: 265–72

    Article  PubMed  CAS  Google Scholar 

  31. Karanfil LV, Josephson A. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13: 195–200

    Article  PubMed  CAS  Google Scholar 

  32. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1148–53

    PubMed  CAS  Google Scholar 

  33. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77–83

    Article  PubMed  CAS  Google Scholar 

  34. Baquero F, Loza E. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr Infect Dis J1994; 13 Suppl. 1: 9–14

    Google Scholar 

  35. Marton A. Epidemiology of resistant pneumococci in Hungary. Microb Drug Resist 1995; 1(2): 127–30

    Article  PubMed  CAS  Google Scholar 

  36. Geslin P, Buu-Hoi A, Fremaux A. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970–1979. Clin Infect Dis 1992; 15: 95–8

    Article  PubMed  CAS  Google Scholar 

  37. Baquero T. Epidemiology and management of penicillin-resistant pneumococci. Curr Opinion Infect Dis 1996; 9: 372–9

    Article  Google Scholar 

  38. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995; 14: 751–9

    Article  PubMed  CAS  Google Scholar 

  39. Soares S, Kristinsson KG, Musser JM. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158–63

    Article  PubMed  CAS  Google Scholar 

  40. Arnold KE, Leggiadro RJ, Breiman RF, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr 1996; 128: 757–64

    Article  PubMed  CAS  Google Scholar 

  41. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19: 884–90

    Article  PubMed  CAS  Google Scholar 

  42. Moreno F, Crisp C, Jorgensen HJ, et al. The clinical and molecular epidemiology of bacteremias at a university hospital caused by pneumococci not susceptible to penicillin. J Infect Dis 1995; 172: 427–32

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Uppsala University Hospital, S-751 85, Uppsala, Sweden

    Otto Cars

Authors
  1. Otto Cars
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cars, O. Colonisation and Infection with Resistant Gram-Positive Cocci. Drugs 54 (Suppl 6), 4–10 (1997). https://doi.org/10.2165/00003495-199700546-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199700546-00004

Keywords

Search

Navigation